A micro costing of NHS cancer genetic services

about

Microcosting quantity data collection methods.Direct costs of radiotherapy for rectal cancer: a microcosting study The costs of colonoscopy in a Canadian hospital using a microcosting approach

P2860

Q33470193-11B8279E-F35D-4B4E-97AC-B60A2BFB9FA2 Q35620648-96E8DE4C-AE9E-4783-B393-C3AF273C5C7E Q42005633-9D364F27-6D97-4F62-9A7C-7373759DA6B9

P2860

A micro costing of NHS cancer genetic services

Item

http://www.wikidata.org/entity/Q36615760

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

A micro costing of NHS cancer genetic services

@ast

A micro costing of NHS cancer genetic services

@en

type

Item

label

A micro costing of NHS cancer genetic services

@ast

A micro costing of NHS cancer genetic services

@en

prefLabel

A micro costing of NHS cancer genetic services

@ast

A micro costing of NHS cancer genetic services

@en

P1476

A micro costing of NHS cancer genetic services

@en

P2093

B France

http://www.w3.org/2001/XMLSchema#string

C Wilkinson

http://www.w3.org/2001/XMLSchema#string

G L Griffith

http://www.w3.org/2001/XMLSchema#string

GenQuest Research Team

http://www.w3.org/2001/XMLSchema#string

J Gray

http://www.w3.org/2001/XMLSchema#string

J Turner

http://www.w3.org/2001/XMLSchema#string

R Butler

http://www.w3.org/2001/XMLSchema#string

R Tudor-Edwards

http://www.w3.org/2001/XMLSchema#string

P2860

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

Identification of the breast cancer susceptibility gene BRCA2

Factors influencing patients' decisions to decline cancer genetic counseling services.

Costs, benefits and limitations of genetic testing for cancer risk.

Ethical, social and economic issues in familial breast cancer: a compilation of views from the E.C. Biomed II Demonstration Project

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

Why do women attend familial breast cancer clinics?

Cancer genetics services: a systematic review of the economic evidence and issues.

A randomised controlled trial of breast cancer genetics services in South East Scotland: psychological impact

Estimating the survival benefits gained from providing national cancer genetic services to women with a family history of breast cancer.

P2888

sj.bjc.6602270

P304

60-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6602270

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Paul Bennett

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8143601

http://www.w3.org/2001/XMLSchema#string

P698

15583691

http://www.w3.org/2001/XMLSchema#string

P932

2361743

http://www.w3.org/2001/XMLSchema#string

A micro costing of NHS cancer genetic services

about

P2860

P2860

A micro costing of NHS cancer genetic services

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932